Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001049479 | SCV001213528 | benign | Nemaline myopathy 2 | 2024-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031542 | SCV004978249 | uncertain significance | Inborn genetic diseases | 2023-12-14 | criteria provided, single submitter | clinical testing | The c.10276C>A (p.L3426M) alteration is located in exon 71 (coding exon 69) of the NEB gene. This alteration results from a C to A substitution at nucleotide position 10276, causing the leucine (L) at amino acid position 3426 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001049479 | SCV001461936 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |